A bill to amend titles XI and XVIII of the Social Security Act to provide greater transparency of discounts provided by drug manufacturers, to establish requirements relating to pharmacy-negotiated price concessions, and for other purposes.
About This Bill
Committee
Latest Action · July 24, 2019
Read twice and referred to the Committee on Finance.
Phair Relief Act of 2019
This bill establishes and otherwise modifies requirements for pharmacy benefit managers (PBMs), particularly with respect to the disclosure of certain drug pricing information.
Among other things, the bill (1) requires PBMs to pass on a minimum percentage of negotiated rebates, discounts, or price concessions to plan sponsors; (2) temporarily requires negotiated prices for covered drugs under the Medicare prescription drug benefit to be provided at the point-of-sale; and (3) requires the Centers for Medicare & Medicaid Services to establish certain quality measures for determining pharmacy incentive payments.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.